Startups channel feed – Endpoints News

Startups channel feed

George Church backs a startup solution to the massive gene therapy manufacturing bottleneck

5 years ago

An Oxford spinout raises $44M as it looks to resurrect an old Roche antibody in pursuit of a rare disease

5 years ago

MPM, DCVC Bio back $53M round for a bold concept: Let patients make their own CAR-T in vivo

5 years ago

Elevation Oncology bags $65M to push failed Merrimack drug through PhII

5 years ago

Here's a $200M China startup idea — if you can read beyond the big words

5 years ago

One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new field

5 years ago

A pharma R&D chief jumps to a budding new startup factory — and this time he’s found 'something completely different’

5 years ago

Chasing a 'master modulator' in the endocannabinoid system, biotech upstart promises to shake up neuropsychiatric treatments

5 years ago

Kira Pharmaceuticals emerges from stealth with $46M and new CEO to lead complement therapy mission

5 years ago

Decibel Therapeutics raises $82M as Laurence Reid looks to steer gene therapy pivot

5 years ago

What do the top 10 biotech M&A deals of 2020 tell us? Premiums are in, bolt-ons rule and the ADC comeback is on

5 years ago

Flagship launches Senda Biosciences with $88M in backing, looking to pioneer the field of 'Intersystems Biology'

5 years ago

Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism

5 years ago

Can B cells break the boundaries of cell therapy? Longwood startup has $52M to prove a new engineering tech

5 years ago

Pfizer scoops up an antibiotic in rare M&A deal, bagging a virtual startup operating on a shoestring budget

5 years ago

Bo Cumbo jumps from the top commercial post at Sarepta to the helm of a gene therapy startup with some influential backers, big plans and $107M

5 years ago

A long-haul biotech with some impressive backers and big goals recruits a major league R&D exec to the helm. What’s next?

5 years ago

Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals

5 years ago

Venrock takes the wrap off its first microbiome startup, armed with $50M, a CEO from 23andMe and two founders from Stanford

5 years ago

The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased

5 years ago

The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them

5 years ago

A pharma exec gets $100M to chase a cancer-fighting idea uncovered in a 2017 Novartis study

5 years ago

With a $4M federal grant, Lumen jumps into the Covid-19 treatment race

5 years ago

Flagship's next big technological bet? The cloud

5 years ago

First page Previous page 51 52 535455 56 57 Next page Last page